163 related articles for article (PubMed ID: 34600143)
1. Albumin in the management of hepatic encephalopathy: A systematic review and meta-analysis.
Is B; Bombassaro IZ; Tovo CV; de Mattos ÂZ; Ahlert M; Chiesa T; de Mattos AA
Ann Hepatol; 2021 Dec; 26():100541. PubMed ID: 34600143
[TBL] [Abstract][Full Text] [Related]
2. Long-term albumin administration in patients with cirrhosis and ascites: A meta-analysis of randomized controlled trials.
Sandi BB; Leão GS; de Mattos AA; de Mattos ÂZ
J Gastroenterol Hepatol; 2021 Mar; 36(3):609-617. PubMed ID: 32914468
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis: Efficacy and safety of albumin in the prevention and treatment of complications in patients with cirrhosis.
Leache L; Gutiérrez-Valencia M; Saiz LC; Uriz J; Bolado F; García-Erce JA; Cantarelli L; Erviti J
Aliment Pharmacol Ther; 2023 Mar; 57(6):620-634. PubMed ID: 36524316
[TBL] [Abstract][Full Text] [Related]
4. Branched-chain amino acids for people with hepatic encephalopathy.
Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177
[TBL] [Abstract][Full Text] [Related]
5. Branched-chain amino acids for people with hepatic encephalopathy.
Gluud LL; Dam G; Les I; Marchesini G; Borre M; Aagaard NK; Vilstrup H
Cochrane Database Syst Rev; 2017 May; 5(5):CD001939. PubMed ID: 28518283
[TBL] [Abstract][Full Text] [Related]
6. Branched-chain amino acids for people with hepatic encephalopathy.
Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
Cochrane Database Syst Rev; 2015 Sep; (9):CD001939. PubMed ID: 26377410
[TBL] [Abstract][Full Text] [Related]
7. Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials.
Bai Z; Wang L; Wang R; Zou M; Méndez-Sánchez N; Romeiro FG; Cheng G; Qi X
Hepatol Int; 2022 Dec; 16(6):1468-1483. PubMed ID: 36048318
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of albumin infusion for overt hepatic encephalopathy: A systematic review and meta-analysis.
Teh KB; Loo JH; Tam YC; Wong YJ
Dig Liver Dis; 2021 Jul; 53(7):817-823. PubMed ID: 34011479
[TBL] [Abstract][Full Text] [Related]
9. Albumin administration in patients with decompensated liver cirrhosis: a meta-analytic update.
Ashour AA; Atta MA; Sadek KW; Obaid KR; Ashour MA; Ashour A; Danjuma MI; Doi SA; ElZouki AN
Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):479-486. PubMed ID: 32976190
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of albumin for the treatment of hepatic encephalopathy: an updated systematic review and meta-analysis of randomized controlled trials.
Murtaza F; Mathew M; Fagbamila O; Subramani S; Nimal S; Nyshita VN; Priya V; Sany AT; Kumar Y; Cicani L; Ehsan M; Kandel K
Ann Med Surg (Lond); 2024 Jun; 86(6):3416-3422. PubMed ID: 38846811
[TBL] [Abstract][Full Text] [Related]
11. Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study.
Simón-Talero M; García-Martínez R; Torrens M; Augustin S; Gómez S; Pereira G; Guevara M; Ginés P; Soriano G; Román E; Sánchez-Delgado J; Ferrer R; Nieto JC; Sunyé P; Fuentes I; Esteban R; Córdoba J
J Hepatol; 2013 Dec; 59(6):1184-92. PubMed ID: 23872605
[TBL] [Abstract][Full Text] [Related]
12. Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis.
Shen YC; Chang YH; Fang CJ; Lin YS
Nutr J; 2019 Jul; 18(1):34. PubMed ID: 31279342
[TBL] [Abstract][Full Text] [Related]
13. Albumin for cirrhotic patients with extraperitoneal infections: A meta-analysis.
Leão GS; John Neto G; Jotz RF; Mattos AA; Mattos ÂZ
J Gastroenterol Hepatol; 2019 Dec; 34(12):2071-2076. PubMed ID: 31353630
[TBL] [Abstract][Full Text] [Related]
14. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Gluud LL; Vilstrup H; Morgan MY
Cochrane Database Syst Rev; 2016 May; 2016(5):CD003044. PubMed ID: 27153247
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
Zacharias HD; Zacharias AP; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790
[TBL] [Abstract][Full Text] [Related]
16. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Gluud LL; Vilstrup H; Morgan MY
Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid for primary biliary cirrhosis.
Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD000551. PubMed ID: 23235576
[TBL] [Abstract][Full Text] [Related]
18. l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials.
Bai M; Yang Z; Qi X; Fan D; Han G
J Gastroenterol Hepatol; 2013 May; 28(5):783-92. PubMed ID: 23425108
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of IV albumin for non-spontaneous bacterial peritonitis infection among patients with cirrhosis: A systematic review and meta-analysis.
Wong YJ; Qiu TY; Tam YC; Mohan BP; Gallegos-Orozco JF; Adler DG
Dig Liver Dis; 2020 Oct; 52(10):1137-1142. PubMed ID: 32586766
[TBL] [Abstract][Full Text] [Related]
20. Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis.
Bai Z; Bernardi M; Yoshida EM; Li H; Guo X; Méndez-Sánchez N; Li Y; Wang R; Deng J; Qi X
Aging (Albany NY); 2019 Oct; 11(19):8502-8525. PubMed ID: 31596729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
